A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency

Launched by PASCOE PHARMAZEUTISCHE PRAEPARATE GMBH · May 14, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how Vitamin-C Injektopas® (a form of vitamin C) can help people who have a deficiency of this important nutrient. The study aims to understand which symptoms improve when patients receive this treatment, especially those with chronic (long-lasting) or acute (sudden) diseases that might be linked to low vitamin C levels. Researchers want to learn more about the overall health of these patients and how well they tolerate the treatment.

To participate in this study, you need to be at least 18 years old and have a confirmed vitamin C deficiency. However, certain conditions, like allergies to the treatment, kidney problems, or specific blood disorders, may prevent you from joining. If you do take part, you can expect regular check-ins about your symptoms and overall health as the study progresses. This research aims to provide valuable information that could help improve care for patients with vitamin C deficiency in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with vitamin C deficiency
• • Age ≥ 18 years
• Exclusion Criteria:
• • Hypersensitivity to the active ingredient or any of the excipients
• • Oxalate urolithiasis
• • Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
• • Renal insufficiency
• • Glucose-6-phosphate dehydrogenase deficiency/defect
• • Pregnant/breastfeeding women